JFNAX vs. JARTX

Last updated Jun 25, 2026

JFNAX (Janus Henderson Global Life Sciences Fund Class A) and JARTX (Janus Henderson Forty Fund) are both mutual funds - JFNAX is a Health & Biotech Equities fund managed by Janus Henderson, while JARTX is a Large Cap Growth Equities fund managed by Janus Henderson. Over the past 10 years, JFNAX returned 11.77%/yr vs 16.24%/yr for JARTX. A 0.72 correlation means they provide meaningful diversification when combined. JFNAX charges 0.98%/yr vs 1.20%/yr for JARTX.

Performance

JFNAX vs. JARTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Janus Henderson Global Life Sciences Fund Class A (JFNAX) and Janus Henderson Forty Fund (JARTX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, JFNAX achieves a 3.63% return, which is significantly higher than JARTX's 0.94% return. Over the past 10 years, JFNAX has underperformed JARTX with an annualized return of 11.77%, while JARTX has yielded a comparatively higher 16.24% annualized return.

JFNAX

• 1D: 1.24%
• 1M: 3.85%
• YTD: 3.63%
• 6M: 2.62%
• 1Y: 32.79%
• 3Y*: 11.55%
• 5Y*: 7.38%
• 10Y*: 11.77%

JARTX

• 1D: -2.65%
• 1M: -2.72%
• YTD: 0.94%
• 6M: -0.12%
• 1Y: 12.47%
• 3Y*: 19.71%
• 5Y*: 8.45%
• 10Y*: 16.24%

*Multi-year figures are annualized to reflect compound growth (CAGR)

JFNAX vs. JARTX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
JFNAX Janus Henderson Global Life Sciences Fund Class A	3.63%	24.61%	3.41%	7.35%	-2.86%	6.59%	25.42%	28.98%	4.00%	22.35%
JARTX Janus Henderson Forty Fund	0.94%	17.88%	27.76%	39.50%	-33.81%	22.30%	38.69%	36.30%	1.10%	29.05%

Correlation

The correlation between JFNAX and JARTX is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.28
Correlation (3Y) Calculated over the trailing 3-year period	0.45
Correlation (5Y) Calculated over the trailing 5-year period	0.58
Correlation (10Y) Calculated over the trailing 10-year period	0.65
Correlation (All Time) Calculated using the full available price history since Jul 6, 2009	0.72

Over the past year, the correlation between JFNAX and JARTX has dropped to 0.28 - well below their long-term average of 0.72, suggesting their price drivers have been diverging.

Return for Risk

JFNAX vs. JARTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JFNAX

JFNAX Risk / Return Rank: 73
JFNAX Sharpe Ratio Rank: 76
JFNAX Sortino Ratio Rank: 77
JFNAX Omega Ratio Rank: 65
JFNAX Calmar Ratio Rank: 83
JFNAX Martin Ratio Rank: 63

JARTX

JARTX Risk / Return Rank: 10
JARTX Sharpe Ratio Rank: 11
JARTX Sortino Ratio Rank: 11
JARTX Omega Ratio Rank: 11
JARTX Calmar Ratio Rank: 9
JARTX Martin Ratio Rank: 10

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JFNAX vs. JARTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Janus Henderson Global Life Sciences Fund Class A (JFNAX) and Janus Henderson Forty Fund (JARTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	JFNAX	JARTX	Difference
Sharpe ratio: Return per unit of total volatility	2.28	0.80	+1.49
Sortino ratio: Return per unit of downside risk	3.31	1.18	+2.12
Omega ratio: Gain probability vs. loss probability	1.40	1.15	+0.25
Calmar ratio: Return relative to maximum drawdown	3.59	0.78	+2.81
Martin ratio: Return relative to average drawdown	11.39	2.49	+8.90

JFNAX vs. JARTX - Sharpe Ratio Comparison

The current JFNAX Sharpe Ratio is 2.28, which is higher than the JARTX Sharpe Ratio of 0.80. The chart below compares the historical Sharpe Ratios of JFNAX and JARTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

JFNAX vs. JARTX - Drawdown Comparison

The maximum JFNAX drawdown since its inception was -31.07%, smaller than the maximum JARTX drawdown of -56.70%. Use the drawdown chart below to compare losses from any high point for JFNAX and JARTX.

Drawdown Indicators

	JFNAX	JARTX	Difference
Max Drawdown Largest peak-to-trough decline	-31.07%	-56.70%	+25.63%
Max Drawdown (1Y) Largest decline over 1 year	-9.71%	-19.19%	+9.48%
Max Drawdown (3Y) Largest decline over 3 years	-21.28%	-22.22%	+0.94%
Max Drawdown (5Y) Largest decline over 5 years	-22.29%	-41.09%	+18.80%
Max Drawdown (10Y) Largest decline over 10 years	-27.39%	-41.09%	+13.70%
Current Drawdown Current decline from peak	0.00%	-7.22%	+7.22%
Average Drawdown Average peak-to-trough decline	-6.28%	-16.81%	+10.53%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.06%	6.00%	-2.94%

Volatility

JFNAX vs. JARTX - Volatility Comparison

The current volatility for Janus Henderson Global Life Sciences Fund Class A (JFNAX) is 5.66%, while Janus Henderson Forty Fund (JARTX) has a volatility of 8.02%. This indicates that JFNAX experiences smaller price fluctuations and is considered to be less risky than JARTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	JFNAX	JARTX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.66%	8.02%	-2.36%
Volatility (6M) Calculated over the trailing 6-month period	11.44%	14.98%	-3.54%
Volatility (1Y) Calculated over the trailing 1-year period	15.27%	18.78%	-3.51%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	15.95%	22.21%	-6.26%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.36%	21.54%	-4.18%

JFNAX vs. JARTX - Expense Ratio Comparison

JFNAX has a 0.98% expense ratio, which is lower than JARTX's 1.20% expense ratio.

Dividends

JFNAX vs. JARTX - Dividend Comparison

JFNAX's dividend yield for the trailing twelve months is around 4.40%, less than JARTX's 13.53% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
JARTX Janus Henderson Forty Fund	13.53%	13.65%	11.51%	9.10%	0.06%	10.26%	8.38%	7.05%	8.95%	14.50%	6.57%	15.93%
JFNAX Janus Henderson Global Life Sciences Fund Class A	4.40%	4.56%	5.74%	4.28%	0.08%	9.90%	7.82%	6.18%	13.55%	1.03%	0.97%	8.93%

Frequently Asked Questions

Can I hold both JFNAX and JARTX in my portfolio?

JFNAX and JARTX have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, JFNAX or JARTX?

JARTX has higher volatility (8.02%) compared to JFNAX (5.66%). In terms of maximum drawdown, JFNAX dropped -31.07% vs JARTX's -56.70%.

Which has better risk-adjusted returns?

JFNAX currently has the higher Sharpe Ratio (2.28 vs 0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.